Anrotinib hydrochloride is a chemically targeted drug, the main active ingredient of which is Anrotinib hydrochloride, which is a multi-target receptor tyrosine kinase inhibitor, and it can impede tumor angiogenesis and inhibit tumor cell growth. It is a multi-target receptor tyrosine kinase inhibitor that inhibits the production of various types of intravascular growth factor receptor kinases, thereby delaying and inhibiting the further spread and metastasis of tumor cells. Clinically, Anrotinib hydrochloride is suitable for non-small cell lung cancer, colorectal cancer, thyroid cancer and other malignant tumor diseases.